Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 226Generated: October 26, 2026

4-Bromo-2-nitroanisole → cis-3,5-Dimethyl-1-[4-(methyloxy)-3-nitrophenyl]piperazine

https://huagongshe.com/reaction/226

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-Bromo-2-nitroanisoleHCID 118533—
Reactantrel-(2R,6S)-2,6-dimethylpiperazineHCID 6950261—
ReagentCesium carbonateHCID 10796—
CatalystBinap, (A+-)-HCID 634876—
CatalystPalladium (II) acetateHCID 4144353—
Solvent1,4-DioxaneHCID 31275—
Productcis-3,5-Dimethyl-1-[4-(methyloxy)-3-nitrophenyl]piperazineHCID 5900705289.79%

Reaction Conditions

Temperature100 °C

Reaction Steps

To a solution of 4-bromo-1-methoxy-2-nitrobenzene (1500 mg, 6.46 mmol) in dioxane (40 mL) was added (2R,6S)-2,6-dimethylpiperazine (2215 mg, 19.39 mmol) followed by cesium carbonate (3159 mg, 9.70 mmol), 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (564 mg, 0.91 mmol) and diacetoxypalladium (145 mg, 0.65 mmol). The resulting mixture was heated at 100 °C under argon over night (black). LCMS Ok. The solids were filtered through celite and washed with ethyl acetate. The ethyl acetate was evaporated under reduced pressure and the crude product was purified by flash- chromatograpy eluated with Dichloromethane/ 2 M NH3 in Methanol 100/0 =>80/20 over 20 min. The pure fractions was collected and concentrated to give (3R,5S)-1-(4-methoxy-3-nitrophenyl)-3,5-dimethylpiperazine (1540 mg, 90 %) as red solid.

Provenance & Evidence

Source dataset750 AstraZeneca ELN dataset
ORD IDord-5dbc6ee86ad94d33b87d1fb77112c522
Source note750 AstraZeneca ELN dataset